Short-Term Solution Or Long-Term Strategy? Planning For Outsourced Drug Development Shifts

Source: Cambrex

Looking back over the past 2 years, the pandemic continues to test all standards and norms associated with drug development, including timelines, regulatory processes and inspections, manufacturing, and supply chain management. Through strategic partnerships and outsourcing strategies, pharmaceutical and biotech companies are enabling acceleration through collaboration.

As we begin to look forward to the future of drug development, view a panel discussion examining new short- and long-term CDMO and supply chain strategies. Our panel, comprised of industry consultants and early development experts, discussed:

  • Approaches for building your early development outsourcing strategy
  • Considerations for vendor selection for pre-IND and phase-appropriate sourcing to mitigate supply chain disruption
  • Global vs. local sourcing strategies – from drug discovery to analytical and biopharmaceutical testing to manufacturing
  • Regulatory considerations for accelerating drug development
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online